• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    CuraTeQ Biologics finishes Phase 1 study of Denosumab biosimilar

    INDPHARMAPOST

    CuraTeQ Biologics receives positive opinion for biosimilar Dyrupeg from EMA

    INDPHARMAPOST

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.